ENZO BIOCHEM, Inc. (NY:ENZ)
5.19
0.19 (3.53%)
| ENZO BIOCHEM, Inc. (NY:ENZ) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $5.38 | 52 Week High | $7.98 | ||
| Open | $5.17 | 52 Week Low | $2.70 | ||
| Day High | $5.30 | P/E | 8.24 | ||
| Day Low | $5.07 | EPS | $0.63 | ||
| Volume | 104,420 | ||||
| More ENZ Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| APP | 1 | CGLD | 1 |
| GRS | 1 | ALNY | 1 |
| AVII | 1 | GETA | 1 |
| ISIS | 1 | GEN | 1 |
Entities who have mentioned ENZ
- Michael Dell | View Related Stories »
- Notable Mergers and Acquisitions | View Related Stories »
- Rodman & Renshaw | View Related Stories »
- Twitter | View Related Stories »
- Lazard | View Related Stories »
View All Major News StreetInsider.com Major News for ENZ
- Enzo Biochem (ENZ) Reports Q4 Loss of $0.14, Misses by 6c
- Enzo Biochem (ENZ) Reports Q3 Loss of $0.11
- Enzo Biochem (ENZ) Reports a Q2 Loss on Record Revenues
View All ReportsStreetInsider.com Reports on ENZ
- Enzo Biochem (ENZ) Reports Q4 Loss of $0.14, Misses by 6c
- Rodman & Renshaw Initiates Coverage of Enzo Biochem (ENZ) with a Market Outperform
- Enzo Biochem (ENZ) Reports Q3 Loss of $0.11
- Notable Mergers and Acquisitions of the Day 3/13: APP, ENZ, GRS
- Enzo Biochem (ENZ) Buys Assay Designs For $12.2 Million
View All Press ReleasesCompany Press Releases on ENZ
- Enzo Biochem, Inc. Announces Departure of Its Secretary and Treasurer
- Enzo Biochem's Clinical Lab Enters Exclusive Agreement with GeneNews to Market Blood Test for Colorectal Cancer
- GeneNews partners with Enzo Clinical Labs to market ColonSentry(TM) in the U.S.
- Enzo Biochem Executive to Discuss Oral Immune Regulation Platform at Windhover TA Partnerships 2009 Conference
- Enzo Biochem to Present at Lazard Capital Markets 6th Annual Healthcare Conference
StreetInsider Reports on ENZ by Category
View All BlogsBlogs on ENZ
- Three Top and Bottom Market Sectors for This Week
- Enzo Biochem, Inc. F2Q09 (Qtr End 01/31/09) Earnings Call Transcript
- Enzo Biochem, Inc. F3Q08 (Qtr End 4/30/08) Earnings Call Transcript
- Six Significant Gene Therapy Stocks
- Enzo Biochem F4Q07 (Qtr End 7/31/07) Earnings Call Transcript
View All FilingsSEC Filings on ENZ
- Form 8-K ENZO BIOCHEM INC For: Nov 25
- Form 4 ENZO BIOCHEM INC For: Oct 15 Filed by: KRENITSKY KEVIN
- Form 8-K ENZO BIOCHEM INC For: Oct 14
- Form 10-K ENZO BIOCHEM INC For: Jul 31
Comments on recent ENZ articles
Comments on ENZ
No comments are currently available.
on Mar 12, 2009
at 05:01 PM STAGE 3??????? WHEN IS ENZO EVER GET ANYTHING PAST STAGE 2?
Article: Enzo Biochem (ENZ) Reports a Q2 Loss on Record Revenues